Philochem

Philochem is a Swiss subsidiary of the Philogen group (www.philogen.com), acting as discovery center for the group. Philochem’s activities focus on chemical pharmaceutical products and technologies. Read all

NEWS

Philogen announces the authorisation of a clinical trial with PHC-102 for the imaging of renal cell carcinoma.

Read all

PIPELINE

Philochem complements the pipeline of Philogen (which focuses on antibody products) with pharmaceutical products based on small organic molecules. Read all

PARTNERS

Over the years the Philogen group has developed products and technologies in collaboration with leading pharmaceutical companies, including:

Philochem is a fully-owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy